217 related articles for article (PubMed ID: 36525505)
1. Notch-dependent cooperativity between myeloid lineages promotes Langerhans cell histiocytosis pathology.
Kvedaraite E; Milne P; Khalilnezhad A; Chevrier M; Sethi R; Lee HK; Hagey DW; von Bahr Greenwood T; Mouratidou N; Jädersten M; Lee NYS; Minnerup L; Tan Y; Dutertre CA; Benac N; Hwang YY; Lum J; Loh AHP; Jansson J; Teng KWW; Khalilnezhad S; Xu W; Resteu A; Tey HL; Guan NL; Larbi A; Howland SW; Arnell H; Andaloussi SEL; Braier J; Rassidakis G; Galluzzo L; Dzionek A; Henter JI; Chen J; Collin M; Ginhoux F
Sci Immunol; 2022 Dec; 7(78):eadd3330. PubMed ID: 36525505
[TBL] [Abstract][Full Text] [Related]
2. JAG2 signaling induces differentiation of CD14
Schwentner R; Jug G; Kauer MO; Schnöller T; Waidhofer-Söllner P; Holter W; Hutter C
J Leukoc Biol; 2019 Jan; 105(1):101-111. PubMed ID: 30296338
[TBL] [Abstract][Full Text] [Related]
3. Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells.
Hutter C; Kauer M; Simonitsch-Klupp I; Jug G; Schwentner R; Leitner J; Bock P; Steinberger P; Bauer W; Carlesso N; Minkov M; Gadner H; Stingl G; Kovar H; Kriehuber E
Blood; 2012 Dec; 120(26):5199-208. PubMed ID: 23074278
[TBL] [Abstract][Full Text] [Related]
4. Increased AXL
Olexen CM; Risnik D; Lava MC; Dalla Vecchia GL; Rosso DA; Errasti AE; Carrera Silva EA
Clin Immunol; 2024 Jun; 263():110203. PubMed ID: 38575046
[TBL] [Abstract][Full Text] [Related]
5. CSF1R Is Required for Differentiation and Migration of Langerhans Cells and Langerhans Cell Histiocytosis.
Lonardi S; Scutera S; Licini S; Lorenzi L; Cesinaro AM; Gatta LB; Castagnoli C; Bollero D; Sparti R; Tomaselli M; Medicina D; Calzetti F; Cassatella MA; Facchetti F; Musso T; Vermi W
Cancer Immunol Res; 2020 Jun; 8(6):829-841. PubMed ID: 32238382
[TBL] [Abstract][Full Text] [Related]
6. Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?
Berres ML; Merad M; Allen CE
Br J Haematol; 2015 Apr; 169(1):3-13. PubMed ID: 25430560
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow-derived myeloid progenitors as driver mutation carriers in high- and low-risk Langerhans cell histiocytosis.
Xiao Y; van Halteren AGS; Lei X; Borst J; Steenwijk E; de Wit T; Grabowska J; Voogd R; Kemps P; Picarsic J; van den Bos C; Borst J
Blood; 2020 Nov; 136(19):2188-2199. PubMed ID: 32750121
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 loop model for pathogenesis of Langerhans cell histiocytosis.
Murakami I; Matsushita M; Iwasaki T; Kuwamoto S; Kato M; Nagata K; Horie Y; Hayashi K; Imamura T; Morimoto A; Imashuku S; Gogusev J; Jaubert F; Takata K; Oka T; Yoshino T
Cell Commun Signal; 2015 Feb; 13():13. PubMed ID: 25889448
[TBL] [Abstract][Full Text] [Related]
9. RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions.
Hogstad B; Berres ML; Chakraborty R; Tang J; Bigenwald C; Serasinghe M; Lim KPH; Lin H; Man TK; Remark R; Baxter S; Kana V; Jordan S; Karoulia Z; Kwan WH; Leboeuf M; Brandt E; Salmon H; McClain K; Poulikakos P; Chipuk J; Mulder WJM; Allen CE; Merad M
J Exp Med; 2018 Jan; 215(1):319-336. PubMed ID: 29263218
[TBL] [Abstract][Full Text] [Related]
10. Morphoproteomics provides support for TGF-β pathway signaling in the osteoclastogenesis and immune dysregulation of osteolytic Langerhans cell histiocytosis.
Alexandrescu S; Tatevian N; Czerniak BA; Covinsky MH; Burns NK; Brown RE
Int J Clin Exp Pathol; 2012; 5(6):503-11. PubMed ID: 22949932
[TBL] [Abstract][Full Text] [Related]
11. JAK2-mutated Langerhans cell histiocytosis associated with primary myelofibrosis treated with ruxolitinib.
Bonometti A; Bagnoli F; Fanoni D; Venegoni L; Corti L; Bianchi P; Elli EM; Isimbaldi G; L'Imperio V; Nazzaro G; Passoni E; Berti E
Hum Pathol; 2018 Mar; 73():171-175. PubMed ID: 29107666
[TBL] [Abstract][Full Text] [Related]
12. Langerhans cell histiocytosis in adults: Advances in pathophysiology and treatment.
Kobayashi M; Tojo A
Cancer Sci; 2018 Dec; 109(12):3707-3713. PubMed ID: 30281871
[TBL] [Abstract][Full Text] [Related]
13. Mitogen-activating protein kinase pathway alterations in Langerhans cell histiocytosis.
Jouenne F; Benattia A; Tazi A
Curr Opin Oncol; 2021 Mar; 33(2):101-109. PubMed ID: 33315630
[TBL] [Abstract][Full Text] [Related]
14. Cell(s) of Origin of Langerhans Cell Histiocytosis.
Collin M; Bigley V; McClain KL; Allen CE
Hematol Oncol Clin North Am; 2015 Oct; 29(5):825-38. PubMed ID: 26461145
[TBL] [Abstract][Full Text] [Related]
15. Myeloid cells from Langerhans cell histiocytosis patients exhibit increased vesicle trafficking and an altered secretome capable of activating NK cells.
Hagey DW; Kvedaraite E; Akber M; Görgens A; Javadi J; Von Bahr Greenwood T; Björklund C; Åkefeldt SO; Hannegård-Hamrin T; Arnell H; Dobra K; Herold N; Svensson M; El Andaloussi S; Henter JI; Lourda M
Haematologica; 2023 Sep; 108(9):2422-2434. PubMed ID: 36924254
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults.
Milne P; Bigley V; Bacon CM; Néel A; McGovern N; Bomken S; Haniffa M; Diamond EL; Durham BH; Visser J; Hunt D; Gunawardena H; Macheta M; McClain KL; Allen C; Abdel-Wahab O; Collin M
Blood; 2017 Jul; 130(2):167-175. PubMed ID: 28512190
[TBL] [Abstract][Full Text] [Related]
17. CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions.
McClain KL; Picarsic J; Chakraborty R; Zinn D; Lin H; Abhyankar H; Scull B; Shih A; Lim KPH; Eckstein O; Lubega J; Peters TL; Olea W; Burke T; Ahmed N; Hicks MJ; Tran B; Jones J; Dauser R; Jeng M; Baiocchi R; Schiff D; Goldman S; Heym KM; Wilson H; Carcamo B; Kumar A; Rodriguez-Galindo C; Whipple NS; Campbell P; Murdoch G; Kofler J; Heales S; Malone M; Woltjer R; Quinn JF; Orchard P; Kruer MC; Jaffe R; Manz MG; Lira SA; Parsons DW; Merad M; Man TK; Allen CE
Cancer; 2018 Jun; 124(12):2607-2620. PubMed ID: 29624648
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 Is Expressed in Neoplastic Cells of Langerhans Cell Histiocytosis but Not Reactive Langerhans Cell Proliferations.
Shanmugam V; Craig JW; Hornick JL; Morgan EA; Pinkus GS; Pozdnyakova O
Am J Surg Pathol; 2017 Oct; 41(10):1390-1396. PubMed ID: 28622183
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of Langerhans cell histiocytosis.
Badalian-Very G; Vergilio JA; Fleming M; Rollins BJ
Annu Rev Pathol; 2013 Jan; 8():1-20. PubMed ID: 22906202
[TBL] [Abstract][Full Text] [Related]
20. Langerhans Cell Histiocytosis Associated With Renal Cell Carcinoma Is a Neoplastic Process: Clinicopathologic and Molecular Study of 7 Cases.
Agaimy A; Bonert M; Naqvi A; Wang C; Trpkov K; Dettmar P; Wintzer HO; Stoehr R; Hes O; Williamson SR; Gibson IW; Hartmann A
Am J Surg Pathol; 2020 Dec; 44(12):1658-1665. PubMed ID: 32910018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
